Novartis - M&A Summary and Business Overview

Life ScienceCompany

Novartis M&A Summary

Novartis has acquired 35 companies, including 13 in the last 5 years. A total of 8 acquisitions came from private equity firms. It has also divested 7 assets.

Novartis’ largest acquisition to date was in 2019, when it acquired The Medicines Company for $9.7B. It’s largest disclosed sale occurred in 2014, when it sold Novartis Animal Health to Eli Lilly for $5.4B. Novartis has acquired in 11 different US states, and 6 countries. The Company’s most targeted sectors include life science (84%) and medical products (10%).

Novartis Business Overview

Where is Novartis headquartered?

Novartis is headquartered in Basel, Switzerland.

What is Novartis’ revenue?

Novartis disclosed revenue of 51,820M USD for 2022 and 52,877M USD for 2021.

How many employees does Novartis have?

Novartis has 104,323 employees.

What sector is Novartis in?

Novartis is a life science company.

When was Novartis founded?

Novartis was founded in 1996.

M&A Summary

  • M&A Total Activity38
    • M&A Buy Activity31
    • M&A Sell Activity7
  • Total Sectors Invested 4
  • Total Countries Invested 6
  • M&A Buy/Sell Connections 19
  • M&A Advisors 1

Novartis

Novartis AG

Lichtstrasse 35,
Basel, 4056
Switzerland,
+41 61 324 11 11
www.novartis.com

Novartis is a global healthcare and pharmaceutical enterprise dedicated to advancing medical innovation and enhancing patient well-being. Renowned for its pioneering research and development efforts, Novartis has a comprehensive portfolio encompassing groundbreaking pharmaceuticals, generic medications, biosimilars, and eye care solutions. Novartis was founded in 1996 and is based in Basel, Switzerland.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (2.0/yr) # 21 4 2 - 2 2 31
vol $24.9B $920M $1.5B $3.2B $3.0B $33.6B
Sell (0.2/yr) # 6 - - - 1 - 7
vol $5.5B $5.5B
  38

Most Recent M&A

Company Date Value Type
MorphoSys AG 2024-02-05 3.0B EUR Add-on Acquisition
Planegg, Germany · www.morphosys.com
SanReno Therapeutics (Shanghai) Ltd. 2024-01-05 - Add-on Acquisition
Shanghai, China · www.sanreno.com
DTX Pharma, Inc. 2023-07-17 - Add-on Acquisition
San Diego, California · www.dtxpharma.com
Xiidra 2023-06-30 - Divestiture
Basel, Switzerland · www.xiidra.com
Chinook Therapeutics, Inc. 2023-06-12 3.2B USD Add-on Acquisition
Seattle, Washington · www.chinooktx.com
Gyroscope Therapeutics Ltd. 2021-12-22 1.5B USD Add-on Acquisition
London, United Kingdom · www.gyroscopetx.com
Arctos Medical AG 2021-09-21 - Add-on Acquisition
Liebefeld, Switzerland · www.arctosmedical.com
Cadent Theraputics, Inc. 2020-12-17 770M USD Add-on Acquisition
Cambridge, Massachusetts · www.cadenttx.com
Cadent Therapeutics, Inc. 2020-12-17 - Add-on Acquisition
Cambridge, Massachusetts · www.cadenttx.com
Vedere Bio, Inc. 2020-10-29 150M USD Add-on Acquisition
Cambridge, Massachusetts · www.vederebio.com
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Sandoz International GmbH    - Cimerli 2024-03-04 5
Holzkirchen, Germany · www.sandoz.com Redwood City, California · www.cimerli.com
Sandoz International GmbH    - GSK - Cephalosporin Antibiotics Business 2021-02-11 4
Holzkirchen, Germany · www.sandoz.com Brentford, United Kingdom
Sandoz International GmbH    - Aspen Global, Inc. - Japanese Operations 2019-11-11 3
Holzkirchen, Germany · www.sandoz.com , Japan
Sandoz International GmbH    - AmLactin 2016-12-19 2
Holzkirchen, Germany · www.sandoz.com Maple Grove, Minnesota · www.amlactin.com
MED3OOO, Inc.    - iLIANT Corp. 2006-06-01 2
Pittsburgh, Pennsylvania · www.med3000.com Tampa, Pennsylvania · www.iliant.com
Sandoz International GmbH    - Sabex Holdings Ltd. 2004-08-16 1
Holzkirchen, Germany · www.sandoz.com Boucherville, Quebec · www.sabex.ca
Novartis Pharmaceuticals Corp.    - Fiorinal(R) and Fioricet(R) product lines 2003-01-22 1
East Hanover, New Jersey · www.pharma.us.novartis.com , United States

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 26 (84%) 33.0B (98%) 4 (57%) 5.5B (100%)
Medical Products 3 (10%) 90M (< 1%) 2 (29%) -
Healthcare Services 1 (3%) 470M (1%) 1 (14%) -
Software 1 (3%) - - -
Total 31 $33.6B 7 $5.5B

By Geo

State/Country Buy Value Sell Value
United States 23 28.9B 2 60M
  California 5 590M 1 -
  Massachusetts 5 2.5B - -
  Texas 3 8.7B - -
  New York 2 1.5B - -
  Washington 1 3.2B - -
  Pennsylvania 1 400M - -
  Oklahoma 1 - - -
  New Jersey 1 9.7B - -
  Indiana 1 2.1B - -
  Connecticut 1 200M - -
Switzerland 2 - 5 5.4B
United Kingdom 3 1.6B - -
China 1 - - -
France 1 - - -
Germany 1 3.0B - -
Domestic 2 (6%) - 5 (71%) 5.4B (99%)
Cross-border 29 (94%) 33.6B (100%) 2 (29%) 60M (1%)
Total 31 $33.6B 7 $5.5B

Top M&A Advisors

Financial Deals
Jefferies
1

Deal Values

buy # Total
> $1B 8 $31.3B
$100M to $1B 6 $2.1B
< $100M 2 $100M
TOTAL $33.6B
Largest The Medicines Company
$9.7B (2019-11-24)
sell # Total
> $1B 1 $5.4B
< $100M 1 $60M
TOTAL $5.5B
Largest Novartis Animal Health, Inc.
$5.4B (2014-04-22)

M&A Connections

Deals
Acquired from
Investor(s)
13%
4 (13%)
Strategic(s)
10%
3 (10%)
Divested to
Investor(s)
14%
1 (14%)
Strategic(s)
71%
5 (71%)

 Subscribe to unlock this and 201,535
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Novartis

Life Science Companies , Switzerland Companies